Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.

@article{Bernard1997PropranololAS,
  title={Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.},
  author={Brigitte Bernard and Didier Lebrec and Philippe Mathurin and Pierre Opolon and Thierry Poynard},
  journal={Journal of hepatology},
  year={1997},
  volume={26 2},
  pages={312-24}
}
BACKGROUND/AIMS A meta-analysis of nine selected randomized trials was performed to compare the effects of propranolol and sclerotherapy in the prevention of rebleeding and on survival in patients with cirrhosis. METHODS Five end points were assessed: rebleeding, esophageal rebleeding, death, death due to bleeding, and adverse events. Analyses were performed according to the intention-to-treat method. For each end point, heterogeneity and treatment efficacy were assessed by the Der Simonian… CONTINUE READING